Selected Topics in Myasthenia Gravis最新文献

筛选
英文 中文
Structure-Based Approaches to Antigen-Specific Therapy of Myasthenia Gravis 基于结构的重症肌无力抗原特异性治疗方法
Selected Topics in Myasthenia Gravis Pub Date : 2019-05-06 DOI: 10.5772/INTECHOPEN.84715
Jiang Xu, K. Noridomi, Lin Chen
{"title":"Structure-Based Approaches to Antigen-Specific Therapy of Myasthenia Gravis","authors":"Jiang Xu, K. Noridomi, Lin Chen","doi":"10.5772/INTECHOPEN.84715","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.84715","url":null,"abstract":"A majority of Myasthenia Gravis (MG) cases (~85%) are caused by pathological autoimmune antibodies to muscle nicotinic acetylcholine receptors (nAChRs). An attractive approach to treating MG is therefore blocking the binding of autoimmune antibodies to nAChR, or removing specifically nAChR antibodies, or selectively inhibiting and eliminating nAChR-specific B cells. This chapter will review highresolution structural studies of muscle nAChR and its complexes with antibodies derived from experimental autoimmune Myasthenia Gravis (EAMG). Based on these structural analyses, various strategies, including using small molecules to block the binding of MG autoimmune antibodies, and engineered chimeric nAChR antigen to specifically target and eliminate B cells that produce nAChR-specific antibodies, will be discussed.","PeriodicalId":175221,"journal":{"name":"Selected Topics in Myasthenia Gravis","volume":"62 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114109103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introductory Chapter: Myasthenia Gravis - An Overview 导论章:重症肌无力-概述
Selected Topics in Myasthenia Gravis Pub Date : 2019-04-09 DOI: 10.5772/INTECHOPEN.85761
I. AL-Zwaini, Ali AL-Mayahi
{"title":"Introductory Chapter: Myasthenia Gravis - An Overview","authors":"I. AL-Zwaini, Ali AL-Mayahi","doi":"10.5772/INTECHOPEN.85761","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.85761","url":null,"abstract":"The term myasthenia gravis (MG) is derived from the Greek terms my, asthenia, and gravis, which mean muscle, weakness, and severe, respectively. Myasthenia gravis is a rare potentially fatal chronic autoimmune disorder, in which circulating autoantibodies directed against components of the neuromuscular junction (NMJ) of skeletal muscles, most commonly nicotinic acetylcholine receptor (AChR) and associated protein in the postsynaptic membrane, will block neuromuscular transmission resulting in muscle weakness [1]. The muscle weakness is typically worsened with continued activity, improves on rest, and is of variable severity ranging from mild ocular muscle weakness to severe generalized muscle weakness involving the respiratory muscle with impending respiratory failure.","PeriodicalId":175221,"journal":{"name":"Selected Topics in Myasthenia Gravis","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128981618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Maternal and Neonatal Outcome of Pregnancies with Autoimmune Myasthenia Gravis 自身免疫性重症肌无力孕妇和新生儿的预后
Selected Topics in Myasthenia Gravis Pub Date : 2019-01-24 DOI: 10.5772/INTECHOPEN.83356
Miljana Z Jovandaric, S. Milenković
{"title":"Maternal and Neonatal Outcome of Pregnancies with Autoimmune Myasthenia Gravis","authors":"Miljana Z Jovandaric, S. Milenković","doi":"10.5772/INTECHOPEN.83356","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.83356","url":null,"abstract":"Myasthenia gravis (MG) is an autoimmune neuromuscular disease manifested by the weakness and fatigue in skeletal muscles of the face and extremities. Transient neonatal myasthenia gravis is an uncommon type of MG affecting the newborns with mothers who suffer from the disorder or specific circulating autoantibodies. In most cases, the intensity of transient neonatal MG is not associated with the mothers’ condition but rather with maternal antibody titers. The symptoms of transient neonatal MG are hypotonia, feeding difficulties, weak cry, facial diplegia, and breathing difficulties in the affected newborns. The disease is connected to the passive transplacental transfer of anti-acetylcholine receptor antibodies (anti-AChR) or antimuscle-specific tyrosine kinase antibodies (anti-MuSK) from the affected mother to the infant. The postsynaptic neuromuscular junction is damaged by the circulation of autoimmune antibodies, and the antibodies directed against fetal AChR are responsible for the form of fetal onset. Monitoring of these newborns is necessary in the first 7 days upon birth, since during this period of life, TNM symptoms can be detected, especially on the second day. In pregnancy period, myasthenia gravis symptoms may vary and they frequently worsen, sometimes leading to premature delivery.","PeriodicalId":175221,"journal":{"name":"Selected Topics in Myasthenia Gravis","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130000369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Myasthenic Syndrome in Children 儿童肌无力综合征
Selected Topics in Myasthenia Gravis Pub Date : 2018-12-19 DOI: 10.5772/INTECHOPEN.82512
A. A. Kareem
{"title":"Myasthenic Syndrome in Children","authors":"A. A. Kareem","doi":"10.5772/INTECHOPEN.82512","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.82512","url":null,"abstract":"The myasthenic syndrome in children can be inherited or of acquired autoimmune origin. In the autoimmune syndrome, babies born to a myasthenic mother are floppy at birth with weak cry, ptosis, and impaired respiration. Fortunately, most of these cases are transient and complete recovery will take place after few weeks; however, good supportive measures are needed until recovery. On the other hand, the classical autoimmune myasthenia gravis (MG), which is known as juvenile myasthenia gravis, can occur in children of any age group. It is commonly divided into prepubertal and postpubertal, the latter usually follows adult criteria, is more common in females, generalized, and most of them are seropositive for neuromuscular antibodies. In contrast, in acquired myasthenia gravis that occurs in prepubertal children, there is no sex predilection and patients are less likely seropositive, and ocular myasthenia more likely to occur than postpubertal. An interesting group of childhood myasthenic syndromes is the congenital myasthenic syndrome; this is an uncommon, nonimmune-mediated heterogeneous syndrome with variable presentation, ranging from mild symptoms with little weakness to severe ones that may cause extreme weakness and respiratory failure. Congenital myasthenic syndrome is classified into presynaptic, synaptic, and postsynaptic, and each of them has subtypes, with the postsynaptic syndrome representing the most common type. Many patients with congenital myasthenic syndrome are misdiagnosed with seronegative acquired myasthenia or congenital myopathy; however, advances in disease investigation are showing promise in early and precise diagnosis.","PeriodicalId":175221,"journal":{"name":"Selected Topics in Myasthenia Gravis","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133811106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasmapheresis in Treatment of Myasthenia Gravis 血浆置换治疗重症肌无力
Selected Topics in Myasthenia Gravis Pub Date : 2018-11-05 DOI: 10.5772/INTECHOPEN.81354
V. Voinov
{"title":"Plasmapheresis in Treatment of Myasthenia Gravis","authors":"V. Voinov","doi":"10.5772/INTECHOPEN.81354","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.81354","url":null,"abstract":"","PeriodicalId":175221,"journal":{"name":"Selected Topics in Myasthenia Gravis","volume":"256 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124220974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书